Vibrant Gujarat regional conference to showcase North Gujarat’s pharma sector strength: Gujarat govt

Gandhinagar:  North Gujarat accounts for 12% of the state’s pharmaceuticals manufacturing output, and this sector will be showcased in the Vibrant Gujarat regional conference (VGRC) for the region that will be held in Mehsana next month, said the state govt on Monday.

Mehsana presents significant opportunities in the manufacturing of bulk drugs, APIs, intermediates, and formulations, supported by established companies, stated an official statement, adding: “Patan district complements this with a robust base of pharma MSMEs specialising in injectables and formulations. The district is also witnessing promising growth in the medtech sector, driven by enterprises involved in the manufacturing of vascular interventional devices and essential medical equipment such as hospital trolleys and stretchers.”

North Gujarat is emerging as a region with advanced educational infrastructure. The region is home to institutions such as the Gujarat Medical Education and Research Society (GMERS) medical colleges in Mehsana, Patan, and Sabarkantha districts; Hemchandracharya North Gujarat University in Patan; Gokul Global University in Siddhpur; SK Patel College of Pharmaceutical Education and Research at Ganpat University in Mehsana’s Kherva taluka; Banas Medical College and Research Institute in Palanpur; Siddhpur Dental College and Hospital; and Arrdekta Homoeopathic Medical College and Hospital in Khedbrahma.

Related Posts

NCB Hyderabad raids illegal lab, seizes 69 kg of Alprazolam worth Rs 17.4 crore

The officials identified the substance as Alprazolam manufactured illegally at the lab. HYDERABAD: In one of the largest such seizures in recent times, the Narcotics Control Bureau (NCB), Hyderabad, raided…

Govt Outlines AYUSH Heavy Metal Monitoring Steps In Rajya Sabha

New Delhi: The Ministry of AYUSH has detailed its regulatory framework and ongoing initiatives to monitor heavy metal content in traditional medicines, responding to parliamentary concerns over quality and safety…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Chhattisgarh draws Rs 992.53 Cr worth pharma investment proposals in 18 months

Chhattisgarh draws Rs 992.53 Cr worth pharma investment proposals in 18 months

FSSAI suspends license of Punjab-based Rehaan Healthcare for breach of norms at manufacturing unit

FSSAI suspends license of Punjab-based Rehaan Healthcare for breach of norms at manufacturing unit

Pharma companies in a flux over Trump’s 200% tariff move on generics

Pharma companies in a flux over Trump’s 200% tariff move on generics

Noida Raid Uncovers Suspected ₹2.48-Crore Diversion of Life-Saving Medicines; Probe Expands Into Government Supply Chain and Interstate Network

Noida Raid Uncovers Suspected ₹2.48-Crore Diversion of Life-Saving Medicines; Probe Expands Into Government Supply Chain and Interstate Network

CDSCO Directs Safety Updates for Ibuprofen and Aceclofenac Over Risk of ‘Fixed Drug Eruption’

CDSCO Directs Safety Updates for Ibuprofen and Aceclofenac Over Risk of ‘Fixed Drug Eruption’

Fake Medicines Worth Over Rs 5 Crore Seized From Factory In Uttarakhand’s Dehradun

Fake Medicines Worth Over Rs 5 Crore Seized From Factory In Uttarakhand’s Dehradun